Jennifer Klomp

Jennifer Klomp is an Assistant Professor in the Department of Medicine at Michigan State University. Her research focuses on understanding aberrant kinase activity in KRAS mutant cancers, particularly pancreatic ductal adenocarcinoma (PDAC), and developing targeted therapies. She investigates how ERK kinase supports cancer cell growth using transcriptomics, phosphoproteomics, and functional genetic screens.

Education: PhD in Cellular and Molecular Pharmacology from the University of Illinois at Chicago (201X), followed by postdoctoral training at the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (201X–202X).

Research interests include mechanisms of ERK-driven KRAS-dependent cancer growth, resistance to RAS inhibitors, and improving anti-ERK therapeutic strategies. Current work addresses toxicity and resistance challenges in ERK-targeted therapies.

No specific grants, awards, or lab affiliations explicitly mentioned in the provided text.